ICU Medical Q3 2022 revenue $597.9M; GAAP loss $(0.55)/share; adj EPS $1.75

ICU MEDICAL INC/DE

2022-Q3 EPS reported -$2.47 revenue$1,701,983,000

Revenue $597.9M vs $336.1M YoY (+78%); GAAP net loss $(13.2)M ($(0.55)/diluted share).
Adjusted diluted EPS $1.75 vs $2.07 YoY; adjusted EBITDA $92.6M vs $71.9M.
GAAP gross margin 31% vs 38% YoY; gross profit $186.4M vs $127.8M.
Reaffirmed fiscal year 2022 guidance; no specific guidance numbers provided.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ICU MEDICAL INC/DE reported For the quarter ended September 30, 2022 results: revenue Third quarter 2022 revenue was $597.9 million, net income GAAP net loss for the third quarter of 2022 was $(13.2) million, EPS Adjusted diluted earnings per share for the third quarter of 2022 was $1.75. Guidance reaffirmed.

Period: For the quarter ended September 30, 2022
Revenue: Third quarter 2022 revenue was $597.9 million
Net income: GAAP net loss for the third quarter of 2022 was $(13.2) million
EPS: Adjusted diluted earnings per share for the third quarter of 2022 was $1.75
Guidance: reaffirmed
Result: reported results

Exact text from the filing

ICU Medical Announces Third Quarter 2022 Results The Company Reaffirms 2022 Fiscal Year Guidance

View on SEC.gov

Browse all earnings releases →

ICU MEDICAL INC/DE filing history →

Source: SEC EDGAR

accession 0000883984-22-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.